CRL

CRL Cost of Revenue

$2.71BTTM · USD

Period ending:

CRL FY Cost of RevenueUSD
CRL FY Cost of Revenue1998-12-31: $122.55M1999-12-31: $146.73M2000-12-31: $186.65M2001-12-31: $298.38M2002-12-31: $345.65M2003-12-31: $380.06M2004-12-31: $435.50M2005-12-31: $603.62M2006-12-31: $651.78M2007-12-31: $752.44M2008-12-31: $832.78M2009-12-31: $748.65M2010-12-31: $748.66M2011-12-31: $740.41M2012-12-31: $737.45M2013-12-31: $770.63M2014-12-31: $825.00M2015-12-31: $832.21M2016-12-31: $1.04B2017-12-31: $1.16B2018-12-31: $1.43B2019-12-31: $1.66B2020-12-31: $1.85B2021-12-31: $2.21B2022-12-31: $2.51B2023-12-31: $2.63B2024-12-28: $2.72B2025-12-27: $2.79B$2.79B$0.00
1998-12-312025-12-27

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRL cost of revenue history

Direct costs attributable to producing goods sold. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 27, 2025.

Charles River Laboratories Cost of Revenue — Annual fiscal periods (USD)
Period endingCost of Revenue (USD)
2,789,809,000
2,718,168,000
2,626,853,000
2,513,409,000
2,205,522,000
1,850,392,000
1,662,915,000
1,426,029,000
1,156,683,000
1,037,473,000
832,210,000
825,002,000
770,626,000
737,449,000
740,405,000
748,656,000
748,650,000
832,784,000
752,435,000
651,778,000
603,624,000
435,499,000
380,058,000
345,646,000
298,379,000
186,654,000
146,729,000
122,547,000

Compare cost of revenue

All CRL financial metrics · CRL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.